News & Events

News

Lipidor updates on Phase III study of AKP02 in treatment of psoriasis – half of patients now recruited

STOCKHOLM, Sweden, 20 May 2022 – Lipidor AB (publ) (Nasdaq… Read More

Investor Relations R

Lipidor AB (publ) publishes interim report for first quarter 2022

STOCKHOLM, Sweden, 5 May 2022 – Today, Lipidor AB (publ)… Read More

Investor Relations R

NOTICE OF ANNUAL GENERAL MEETING IN LIPIDOR AB (publ)

STOCKHOLM, Sweden, 3rd May 2022: The shareholders of Lipidor AB… Read More

Events

Biotech Show Case Conference. San Francisco, USA

We will be present during the BIOTECH SHOWCASE conference… Read More

Events

CPHI Worldwide. Frankfurt, Germany

We will be present during CPhI Worldwide in Frankfurt,… Read More

Events

Japan

The Lipidor team will be in Japan, 21-25 October… Read More